** Shares of MedAdvisor MDR.AX rise 18% to A$0.295, on track for its best session since Jan. 8, if current trends hold
** Stock hit its highest level since Oct. 31
** Medical software co initiates formal review process to evaluate strategic options to maximize shareholder value
** Stock has risen 16.3% YTD, as of last close
(Reporting by Sherin Sunny in Bengaluru)
((Sherin.Sunny@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。